A review of methods to estimate cause-specific mortality in presence of competing risks

被引:0
|
作者
Heisey, Dennis M. [1 ]
Patterson, Brent R.
机构
[1] US Geol Survey, Natl Wildlife Hlth Ctr, Madison, WI 53711 USA
[2] Ontario Minist Nat Resources, Wildlife Res & Dev Sect, Peterborough, ON K9J 8M5, Canada
来源
JOURNAL OF WILDLIFE MANAGEMENT | 2006年 / 70卷 / 06期
关键词
Canis latrans; Cox proportional hazards; coyote; cumulative incidence function; Kaplan-Meier; MICROMORT; product limit estimator; survival analysis;
D O I
10.2193/0022-541X(2006)70[1544:AROMTE]2.0.CO;2
中图分类号
Q14 [生态学(生物生态学)];
学科分类号
071012 ; 0713 ;
摘要
Estimating cause-specific mortality is often of central importance for understanding the dynamics of wildlife populations. Despite such importance, methodology for estimating and analying cause-specific mortality has received little attention in wildlife ecology during the past 20 years. The issue of analyzing cause-specific, mutually exclusive events in time is not unique to wildlife. In fact, this general problem has received substantial attention in human biomedical applications within the context of biostatistical survival analysis. Here, we consider cause-specific mortality from a modem biostatistical perspective. This requires carefully defining what we mean by cause-specific mortality and then providing an appropriate hazard-based representation as a competing risks problem. This leads to the general solution of cause-specific mortality as the cumulative incidence function (CIF). We describe the appropriate generalization of the fully nonparametric staggered-entry Kaplan-Meier survival estimator to cause-specific mortality via the nonparametric CIF estimator (NPCIFE), which in many situations offers an attractive alternative to the Heisey-Fuller estimator. An advantage of the NPCIFE is that it lends itself readily to risk factors analysis with standard software for Cox proportional hazards model. The competing risks-based approach also clarifies issues regarding another intuitive but erroneous "cause-specific mortality" estimator based on the Kaplan-Meier survival estimator and commonly seen in the life sciences literature.
引用
收藏
页码:1544 / 1555
页数:12
相关论文
共 50 条
  • [1] Competing risks and cause-specific mortality in patients with pancreatic neuroendocrine tumors
    Li, Zhuyin
    Du, Shuai
    Feng, Wei
    Zhang, Weibo
    Li, Guochuang
    Wei, Junfeng
    Zhang, Guoqing
    Zhao, Longshuan
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2019, 31 (07) : 749 - 755
  • [2] Cause-specific mortality of type B aortic dissection and assessment of competing risks of mortality
    Hysa, Lisa
    Khor, Sara
    Starnes, Benjamin W.
    Chow, Warren B.
    Sweet, Matthew P.
    Nguyen, Jimmy
    Shalhub, Sherene
    [J]. JOURNAL OF VASCULAR SURGERY, 2021, 73 (01) : 48 - +
  • [3] Cause-specific mortality risks of anesthesiologists
    Alexander, BH
    Checkoway, H
    Nagahama, SI
    Domino, KB
    [J]. ANESTHESIOLOGY, 2000, 93 (04) : 922 - 930
  • [4] SIMPLE METHODS FOR TESTING FOR THE PROPORTIONALITY OF CAUSE-SPECIFIC HAZARDS IN COMPETING RISKS MODELS
    NARENDRANATHAN, W
    STEWART, MB
    [J]. OXFORD BULLETIN OF ECONOMICS AND STATISTICS, 1991, 53 (03) : 331 - 340
  • [5] Competing risks analysis of cause-specific mortality in patients with oral squamous cell carcinoma
    Laara, Esa
    Korpi, Jarkko T.
    Pitkanen, Hanna
    Alho, Olli-Pekka
    Kantola, Saara
    [J]. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2017, 39 (01): : 56 - 62
  • [6] Estimating sample size in the presence of competing risks - Cause-specific hazard or cumulative incidence approach?
    Tai, B. C.
    Chen, Z. J.
    Machin, D.
    [J]. STATISTICAL METHODS IN MEDICAL RESEARCH, 2018, 27 (01) : 114 - 125
  • [7] Cause-specific mortality rate of ovarian cancer in the presence of competing risks of death: a nationwide population-based cohort study
    Shim, Seung-Hyuk
    Lim, Myong Cheol
    Lee, Dahhay
    Won, Young-Joo
    Ha, Hyeong In
    Chang, Ha Kyun
    Cho, Hyunsoon
    [J]. JOURNAL OF GYNECOLOGIC ONCOLOGY, 2022, 33 (01)
  • [8] Sample size determination for jointly testing a cause-specific hazard and the all-cause hazard in the presence of competing risks
    Yang, Qing
    Fung, Wing K.
    Li, Gang
    [J]. STATISTICS IN MEDICINE, 2018, 37 (08) : 1389 - 1401
  • [9] Reporting of cause-specific treatment effects in cancer clinical trials with competing risks: A systematic review
    Mell, Loren K.
    Lau, Steven K.
    Rose, Brent S.
    Jeong, Jong-Hyeon
    [J]. CONTEMPORARY CLINICAL TRIALS, 2012, 33 (05) : 920 - 924
  • [10] The mortality risks of smokers in Taiwan - Part I: cause-specific mortality
    Wen, CP
    Tsai, SP
    Chen, CJ
    Cheng, TY
    [J]. PREVENTIVE MEDICINE, 2004, 39 (03) : 528 - 535